Font Size: a A A
Keyword [HBeAg seroconversion]
Result: 1 - 20 | Page: 1 of 2
1. The Relationship Between The HBeAg Seroconversion And The TCM Type Of Syndromes On Lamivudine Treating Chronic Hepatitis B
2. The Change Of Serum SPD-1 Level In Hepatitis B E Antigen(HBeAg)-positive Chronic HBV Patients Before And After Treatment With IFN-α
3. Establishment Of Prediction Model Of HBeAg Seroconversion In Chronic Hepatitis B And Therapeutic Effect Of Traditional Chinese Medicine
4. Genetic Polymorphism Of MxA Promoter Associated With HBeAg Seroconversion In Chronic Hepatitis B Patients Receiving Telbivudine Therapy
5. Roles Of Interleukin-21in HBeAg Seroconversion Of Chronic Hepatitis B Virus Infection
6. Immunomodulatory Effect Of IL-21 In Chronic HBV Infection
7. Prediction Of HBeAg Seroconversion To Nucleos(t)ide Analogues For Hepatitis B E Antigen-positive Chronic Hepatitis B Using Quantitative Detection Of On-treatment Hepatitis B E Antigen
8. Serum Interleukin-37Levels And HBeAg Seroconversion In Chronic HBV Patients
9. Prediction Model Of HBeAg Seroconversion In Patients With HBeAg-positive Chronic Hepatitis B Treated With Peg-interferonα: Establish And Evaluate
10. Long-term Efficacy Of Hepatitis B Vaccine And HBeAg Seroconversion During Chronic Infection
11. The Effect Of Peripheral Blood TGF-Beta On Hbeag Serological Conversion Of Chronic Hepatitis B Patients Treated With Nucleoside Analogues
12. Study For Predicting Hepatitis B E Antigen Seroconversion To Interferon-α In Chronic Hepatitis B Patients
13. Role Of Tfh Cell-mediated Humoral Immune Response In The Process Of HBeAg Seroconversion In CHB Patients Receiving Peginterferon-Αlpha Therapy
14. A Modle Effectively Predicts HBeAg Seroconversion Long Term Entecavir Therapy
15. The Influences Of Dynamic Changes Of T-cell Receptor Repertoires On Antiviral Therapy Outcome In Patients With Chronic Hepatitis B
16. Study On The HBeAg Seroconversion Influenced Factors Of Telbivudine Therapy In Chronic Hepatitis B
17. Analysis Of The Factors Affecting The Outcome Of HBeAg Seroconversion In Antiviral Monotherapy Naive Hbeag Positive CHB Patients
18. Immunological Characteristics Of Different Clinical Outcomes Of Hbeag Serology In Children With Chronic Hbv Infection And Establishment Of Gender And Age-Specific Reference Intervals For Serum Alt,Ast,Akp And Ggt In Children And Its Application In The Nat
19. The Efficacy And Predictive Factors Of Peginterferon Alfa-2a Treatment In HBeAg Positive Chronic Hepatitis B Patients
20. Evaluating Siglec-7 Expression As A Biomarker To Predict HBeAg Seroconversion And Sustained Virological Response Undergoing Pegylated Interferon Therapy In Chronic HBV Patients
  <<First  <Prev  Next>  Last>>  Jump to